paid access
Autoimmune bullous skin disorders — retrospective cohort study
, 1, 1, 1, 1
Affiliations- Katedra i Klinika Dermatologii, Chorób Przenoszonych Drogą Płciową i Immunologii Uniwersytetu Warmińsko-Mazurskiego w Olsztynie
paid access
Abstract
Introduction: Autoimmune bullous disorders is a group of chronic diseases. Bullous pemphigoid is the most common autoimmune bullous disease of all, affecting mainly elderly people in the 8th decade of life, without gender predilection. Pemphigus manifests usually between 45 and 65 years of age, with a female predilection reported in most epidemiological studies. Aim of the study was assessing the prevalence of bullous diseases with respect to their types in different age groups, coexistence with neoplasms and other diseases.
Material and methods: Retrospective analysis of medical histories of patients hospitalized in the Department of Dermatology, Sexually Transmitted Diseases, and Clinical Immunology at the University of Warmia and Mazury in Olsztyn with a diagnosis of bullous diseases between 2015 and 2021.
Results: Seventy-two patients diagnosed with autoimmune bullous diseases were treated in the Department of Dermatology from 2015 to 2021. The mean age of patients was 76 years for pemphigoid diseases and 58 years for pemphigus. A causative agent such as drugs or consumption of bulbous plants was suspected in 10 patients (13.9%). Coexisting neoplasms were present in 12 patients (16.7%). The subjects also had comorbidities, the most common of which was hypertension (23 patients).
Conclusions: The study confirmed most of the epidemiological data: bullous pemphigoid mainly affects the elderly, in the 8th decade of life, while pemphigus usually manifests itself before the age of 65. Symptoms can be provoked by external factors such as drugs, pathogens, UV light, diet, and stress. They can also coexist with other autoimmune and cardiovascular diseases.
Abstract
Introduction: Autoimmune bullous disorders is a group of chronic diseases. Bullous pemphigoid is the most common autoimmune bullous disease of all, affecting mainly elderly people in the 8th decade of life, without gender predilection. Pemphigus manifests usually between 45 and 65 years of age, with a female predilection reported in most epidemiological studies. Aim of the study was assessing the prevalence of bullous diseases with respect to their types in different age groups, coexistence with neoplasms and other diseases.
Material and methods: Retrospective analysis of medical histories of patients hospitalized in the Department of Dermatology, Sexually Transmitted Diseases, and Clinical Immunology at the University of Warmia and Mazury in Olsztyn with a diagnosis of bullous diseases between 2015 and 2021.
Results: Seventy-two patients diagnosed with autoimmune bullous diseases were treated in the Department of Dermatology from 2015 to 2021. The mean age of patients was 76 years for pemphigoid diseases and 58 years for pemphigus. A causative agent such as drugs or consumption of bulbous plants was suspected in 10 patients (13.9%). Coexisting neoplasms were present in 12 patients (16.7%). The subjects also had comorbidities, the most common of which was hypertension (23 patients).
Conclusions: The study confirmed most of the epidemiological data: bullous pemphigoid mainly affects the elderly, in the 8th decade of life, while pemphigus usually manifests itself before the age of 65. Symptoms can be provoked by external factors such as drugs, pathogens, UV light, diet, and stress. They can also coexist with other autoimmune and cardiovascular diseases.
Full Text:
Add to basket: 49.00 PLN
Keywords
pemphigus, pemphigoid, epidemiology
About this articleTitle
Autoimmune bullous skin disorders — retrospective cohort study
Journal
Issue
Article type
Research paper
Pages
93-97
Published online
2022-04-13
Page views
1286
Article views/downloads
41
DOI
Bibliographic record
Forum Dermatologicum 2022;8(2):93-97.
Keywords
pemphigus
pemphigoid
epidemiology
Authors
Adrianna Pyrek
Laura Eliszewska
Natalia Rutecka
Agnieszka Owczarczyk-Saczonek
Waldemar Placek
References (17)- van Beek N, Zillikens D, Schmidt E. Diagnosis of autoimmune bullous diseases. J Dtsch Dermatol Ges. 2018; 16(9): 1077–1091.
- Miyamoto D, Santi CG, Aoki V, et al. Bullous pemphigoid. An Bras Dermatol. 2019; 94(2): 133–146.
- Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. The Lancet. 2019; 394(10201): 882–894.
- Hammers CM, Stanley JR. Recent Advances in Understanding Pemphigus and Bullous Pemphigoid. J Invest Dermatol. 2020; 140(4): 733–741.
- Moro F, Fania L, Sinagra JoL, et al. Bullous Pemphigoid: Trigger and Predisposing Factors. Biomolecules. 2020; 10(10).
- Verheyden MJ, Bilgic A, Murrell DF. A Systematic Review of Drug-Induced Pemphigoid. Acta Derm Venereol. 2020; 100(15): adv00224.
- Tasanen K, Varpuluoma O, Nishie W. Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid. Front Immunol. 2019; 10: 1238.
- Callot V, Bagot M. Pemphigus. Rev Prat. 1994; 44(1): 81–85.
- Porro AM, Seque CA, Ferreira MC, et al. Pemphigus vulgaris. An Bras Dermatol. 2019; 94(3): 264–278.
- Tavakolpour S. Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol Res. 2018; 310(2): 95–106.
- Borrelli F, Capasso R, Izzo AA. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res. 2007; 51(11): 1386–1397.
- Lo Schiavo A, Ruocco E, Brancaccio G, et al. Precautions and suggestions for pemphigus patients. Dermatology. 2001; 203(3): 201–207.
- Jackson SR, Koestenbauer J, Carroll AP, et al. Paraneoplastic bullous pemphigoid - A sign of clear cell renal carcinoma. Urol Case Rep. 2020; 30: 101119.
- Hung TL, Chen YL, Lin KT, et al. Risk of radiotherapy-associated autoimmune bullous disease among Taiwanese patients with breast cancer: a case-control study. Arch Dermatol Res. 2020; 312(1): 69–75.
- Klimaszewska K, Grądzka K. Rola zespołu interdyscyplinarnego w opiece nad pacjentami onkologicznymi, Tom I. Uniwersytet Medyczny w Białymstoku, Białystok 2021: 133–135.
- Chen CT, Hu HY, Chang YT, et al. Cancer is not a risk factor for bullous pemphigoid: 10-year population-based cohort study. Br J Dermatol. 2019; 180(3): 553–558.
- Kridin K, Hundt J, Ludwig R, et al. Anxiety and depression predispose individuals to an autoimmune bullous diseases- bullous pemphigoid: A large-scale population-based cohort study. Current Psychology. 2021.
